178 related articles for article (PubMed ID: 25984151)
1. Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis.
De La Torre M; Arboleya L; Pozo S; Pinto J; Velasco J
NDT Plus; 2011 Jun; 4(3):178-80. PubMed ID: 25984151
[TBL] [Abstract][Full Text] [Related]
2. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
Okuda Y; Takasugi K
Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
[TBL] [Abstract][Full Text] [Related]
3. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report.
Seneschall C; Law S; Roufosse C; Woodham S; Kousios A
J Nephrol; 2024 Jan; ():. PubMed ID: 38206475
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature.
Eriksson P; Mölne J; Wirestam L; Sjöwall C
Front Med (Lausanne); 2021; 8():661101. PubMed ID: 33981717
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.
Yamada S; Tsuchimoto A; Kaizu Y; Taniguchi M; Masutani K; Tsukamoto H; Ooboshi H; Tsuruya K; Kitazono T
CEN Case Rep; 2014 Nov; 3(2):237-243. PubMed ID: 28509209
[TBL] [Abstract][Full Text] [Related]
7. Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
Chantarogh S; Vilaiyuk S; Tim-Aroon T; Worawichawong S
BMC Nephrol; 2017 May; 18(1):159. PubMed ID: 28499374
[TBL] [Abstract][Full Text] [Related]
8. AA amyloidosis associated with systemic-onset juvenile idiopathic arthritis.
Saha A; Chopra Y; Theis JD; Vrana JA; Sethi S
Am J Kidney Dis; 2013 Oct; 62(4):834-8. PubMed ID: 23664546
[TBL] [Abstract][Full Text] [Related]
9. Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Gupta A; Bagri NK; Tripathy SK; Barwad A; Phulware RH; Hari P
Rheumatol Int; 2020 Jan; 40(1):153-159. PubMed ID: 31273457
[TBL] [Abstract][Full Text] [Related]
10. Amyloid A amyloidosis with subcutaneous drug abuse.
Mendoza JM; Peev V; Ponce MA; Thomas DB; Nayer A
J Renal Inj Prev; 2014; 3(1):11-6. PubMed ID: 25340157
[TBL] [Abstract][Full Text] [Related]
11. Secondary, AA, Amyloidosis.
Papa R; Lachmann HJ
Rheum Dis Clin North Am; 2018 Nov; 44(4):585-603. PubMed ID: 30274625
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
[TBL] [Abstract][Full Text] [Related]
13. Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.
Yamagata A; Uchida T; Yamada Y; Nakanishi T; Nagai K; Imakiire T; Oshima N; Kumagai H
BMC Nephrol; 2017 Dec; 18(1):377. PubMed ID: 29287589
[TBL] [Abstract][Full Text] [Related]
14. Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1 syndrome (TRAPS) genes.
Clementi A; Cruz DN; Granata A; Virzì GM; Battaglia G
Clin Kidney J; 2013 Dec; 6(6):613-617. PubMed ID: 24286006
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease.
Redondo-Pachón MD; Enríquez R; Sirvent AE; Andrada E; Noguera-Pons R; Millán I; Amorós F
Ren Fail; 2013; 35(4):547-50. PubMed ID: 23472940
[TBL] [Abstract][Full Text] [Related]
16. Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - effective treatment with tocilizumab.
Kwiatkowska M; Jednacz E; Rutkowska-Sak L
Reumatologia; 2015; 53(3):157-60. PubMed ID: 27407243
[TBL] [Abstract][Full Text] [Related]
17. AA amyloidosis: basic knowledge, unmet needs and future treatments.
Obici L; Merlini G
Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.
Cooper C; Bilbao JE; Said S; Alkhateeb H; Bizet J; Elfar A; Davalos O; Meza AT; Hernandez GT
J Nephropathol; 2013 Jul; 2(3):196-200. PubMed ID: 24475449
[TBL] [Abstract][Full Text] [Related]
20. [Secondary (AA) renal/bone amyloidosis complicating rheumatoid arthritis].
Prkacin I; Skurla B; Pocanić D; Bulum T; Bulimbasić S; Kardum-Skelin I
Acta Med Croatica; 2011 Sep; 65 Suppl 1():217-21. PubMed ID: 23126056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
